Houston Methodist researcher discusses why multi-target therapies are more effective than single-target drugs for neurodegenerative diseases.

Houston Methodist Cypress is leading the hospital system in using innovative, wearable technology to monitor patient care.

For decades, cancer research has largely focused on treating advanced disease. But a new commentary from Houston Methodist researcher may help shift that paradigm upstream.

Gastroenterologists have long managed conditions like irritable bowel syndrome and functional dyspepsia without a clear biological roadmap; a new paper recommends looking at them through a new lens.

Expert consensus statement gives gastroenterologists a common framework for evaluating the clinical definition of "gut health."

At Houston Methodist, surgeon-led, risk-adjusted reporting fostered trust, culture change and measurable gains in mortality and length of stay.

Houston Methodist researchers participated in a prospective study comparing two wireless motility devices and validated the Atmo Capsule from Atmo Biosciences as an effective method for assessing gastrointestinal transit.

New research from Houston Methodist offers a clear glance at how spaceflight affects the surface of the eye.

A Houston Methodist–led clinical trial shows long-lasting relief for chronic rhinitis following temperature-controlled radiofrequency ablation.

Houston Methodist researcher discusses why Lewy pathology must be a critical consideration in the design of clinical trials for neurodegenerative diseases.

New study demonstrates that impedance-controlled multipoint radiofrequency ablation significantly improves symptoms and quality of life for patients with chronic rhinitis.

Seasonal surges reveal where information flow breaks down, where cognitive load spikes and where technology can meaningfully reshape care delivery.

Dr. Omar G. Ahmed and his team have researched chronic rhinosinusitis (CRS) and discovered that race and genetics play a role in how CRS affects patients across races.

New research from a Houston Methodist investigator suggests that tumor-associated B cells may help hepatocellular carcinoma cells evade immune detection, leading to poor outcomes with immune checkpoint inhibition.

Houston Methodist researchers push the envelope with an innovative vacuum coupler that enhances image integrity and offers superior data for open-chest cardiac ultrasound-mediated imaging.

Houston Methodist and Texas Children’s have announced a transformational collaboration to establish the Fondren IBD Transition Program, an initiative designed to support children and young adults living with inflammatory bowel disease (IBD) as they make the transition from pediatric to adult...

Innovative clinic offers comprehensive support for patients and family members experiencing post intensive care syndrome.

Houston Methodist critical care specialist Dr. Hina Faisal has received a National Institutes of Health career development award to investigate whether immersive virtual reality therapy can help prevent ICU delirium.

Houston Methodist researcher discusses why co-pathologies are critically important to study in neurodegenerative diseases.

Study validates a more accurate method for estimating left ventricular filling pressure (LVFP) by echocardiography.

Studies conducted at Houston Methodist on Alzheimer’s disease pathology and Lewy pathology may improve the design of clinical trials for neurodegenerative diseases and patient outcomes.

A Houston Methodist study found that patients on long-term steroids have a 3X higher risk of blood clots after spinal surgery than non steroid users.

Dr. Min Kim came to Houston Methodist with a plan: half his time would be spent modeling lung cancer and metastasis, and the other half caring for patients. But four years into practice, that plan changed abruptly. After his senior partner left for Mayo Clinic, leadership approached him with a question that would reshape his career: Do you want to do the job of division chief with the title, or without it? Dr. Kim took the title and set out to build a program that focused on two emerging pillars: robotic surgery and enhanced recovery after surgery (ERAS). A decade ago, neither was widely adopted in thoracic care. Today, they define the division’s identity.

Dr. Kodali comments on the first and only book on Transplant Oncology—“Transplant Oncology: A Frontier in Multidisciplinary Cancer Care”– published by Elsevier and edited by Dr. Abdelrahim.

A Houston Methodist research team uses functional MRI to capture real-time activity in the human spinal cord regions responsible for bladder control.

A new study evaluates encorafenib, cetuximab and nivolumab in patients with microsatellite-stable (MSS) colorectal cancer.

Houston Methodist taps Dr. Martha Gulati to lead new Davis Women’s Heart Center, a major investment in the prevention, diagnosis and treatment of heart disease in women

At Houston Methodist, three interconnected areas of research are producing innovative technologies to advance treatments for spinal cord injury to restore upper limb function in paralysis patients.

The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

A new generation of congenital heart care is helping patients not just survive but thrive.

At Houston Methodist, innovative language assistance technology is breaking down barriers for patients with limited English proficiency.

New studies on efruxifermin provide the first evidence that cirrhosis caused by metabolic dysfunction–associated steatohepatitis may be reversible.

Through innovative clinical trials, Houston Methodist researchers are enhancing patient outcomes in common neurological conditions using neurosurgical procedures.

New progress unraveling the mechanics of amyotrophic lateral sclerosis (ALS) and Parkinson’s and Alzheimer’s disease has led to clinical trial testing of potential therapeutics.

A clinical trial led by Houston Methodist's Dr. William Ondo suggests that an AI–driven wearable device may benefit patients with essential tremor.

New Research Sheds Light How Spinal Stimulation Amplifies Residual Motor Signals

A Houston Methodist-Rice University study has used machine learning to identify patients at risk of aortic regurgitation complications: women.

Houston Methodist is using artificial intelligence-enabled virtual care platforms and embedded sensors to make its hospital rooms self-aware care spaces.

Rice University and Houston Methodist researchers receive Dunn Collaborative grant to study the brain's response to neural implants.

New Houston Methodist study sheds light on how Alzheimer's disease may contribute to health issues by hijacking the body's ability to regulate metabolism.

A national analysis led by Houston Methodist shows that orbital decompression surgery has declined significantly since the FDA approved teprotumumab.

Dr. Eamonn Quigley calls for a fundamental reset in how the scientific and medical communities — and the public — think about probiotics.

In a comprehensive new review article Houston Methodist's Dr. Eamonn Quigley examines how the gut microbiome contributes to irritable bowel syndrome.

A particular mechanism of cell death induced by gemcitabine can help surviving bladder cancer cells proliferate.

Dr. Eamonn Quigley revisits the origins of small intestinal bacterial overgrowth (SIBO) and issues a warning about its modern overdiagnosis.

Houston Methodist study uses optogenetic stimulation to show how neurons extract information about temporal regularities from dynamic stimuli.

Houston Methodist reveals how it is taking patient experience surveys to the next level with new AI-enabled tools.

A new comprehensive review in Cancers offers the clearest picture yet of how the surgical management of early-stage cervical cancer has evolved since LACC.